Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Kedudukan dalam Saham
#3551
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Harga Saham
$3.74
Modal Pasaran
$4.73B
Perubahan (1 hari)
-3.18%
Perubahan (1 tahun)
-51.80%
Negara
CN
Perdagangan Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Kategori
Healthcare
Sejarah harga saham bagi Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Harga penutupan tertinggi: $3.74 pada 2026-10-01
Harga penutupan terendah: $0.55 pada 2020-04-01
Harga penutupan terendah: $0.55 pada 2020-04-01
Sejarah harga saham Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. dari 2020 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | -17.26% |
| 2025 | -35.40% |
| 2024 | 28.79% |
| 2023 | -42.24% |
| 2022 | -8.97% |
| 2021 | 74.48% |
| 2020 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $755.78 | 7.42% |
CH
|
